Fundz

Who to call at Apimeds Pharmaceuticals US, and when

Fundz watches for the moments Apimeds Pharmaceuticals US starts buying, and tells you who to reach.

  • An alert the day Apimeds Pharmaceuticals US raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Apimeds Pharmaceuticals US, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Apimeds Pharmaceuticals US. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Apimeds Pharmaceuticals Enters into Assignment Agreement with FreeT Inc.

Aug 21, 2026

Contract Type

assignment_agreement

MatawanBiotechnologyHealth CareTherapeuticsBiopharma

Description

On August 19, 2026, Apimeds Pharmaceuticals US, Inc. signed an Assignment and Transfer Agreement with FreeT Inc., acquiring specific Apitox-related rights. This agreement allows Apimeds to take over all interests that FreeT had under the previous Apitox Rights Transfer Agreement from 2015. The Assigned Rights include complete ownership of these rights, which strengthens Apimeds' portfolio in the pharmaceutical sector.

Quick answer

Apimeds Pharmaceuticals Enters into Assignment Agreement with FreeT Inc. (August 21, 2026). Apimeds Pharmaceuticals US is based in Matawan, New Jersey, United States.

What agreement did Apimeds Pharmaceuticals US announce on August 21, 2026?
On August 19, 2026, Apimeds Pharmaceuticals US, Inc. signed an Assignment and Transfer Agreement with FreeT Inc., acquiring specific Apitox-related rights. This agreement allows Apimeds to take over all interests that FreeT had under the previous Apitox Rights Transfer Agreement from 2015.
What does Apimeds Pharmaceuticals US do?
Apimeds is a clinical-stage biopharmaceutical company developing Apitox, an intradermally administered honeybee venom-based toxin.
Where is Apimeds Pharmaceuticals US based?
Apimeds Pharmaceuticals US is based in Matawan, New Jersey, United States.

Source: Fundz verified event record.

Company Information

Company

Apimeds Pharmaceuticals US

Location

100 Matawan Rd

Matawan, New Jersey, United States

About

Apimeds is a clinical-stage biopharmaceutical company developing Apitox, an intradermally administered honeybee venom-based toxin. They are focused on creating potential treatments for osteoarthritis knee pain. The company aims to offer solutions for patients who don't respond adequately to standard non-pharmacologic therapies. Apimeds is dedicated to advancing innovative therapeutic options.

Related People

Erik
Senior decision-maker at this company
••••••••@••••••••

See Erik's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Apimeds Pharmaceuticals US's next move

Learn about Strategic plan

Apimeds Pharmaceuticals US signed a new agreement. Fundz surfaces partnerships and contracts as they are announced.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.